Logo image of CVE.CA

CENOVUS ENERGY INC (CVE.CA) Stock Fundamental Analysis

Canada - TSX:CVE - CA15135U1093 - Common Stock

25.4 CAD
+0.37 (+1.48%)
Last: 11/14/2025, 7:00:00 PM
Fundamental Rating

6

Overall CVE gets a fundamental rating of 6 out of 10. We evaluated CVE against 212 industry peers in the Oil, Gas & Consumable Fuels industry. CVE has an excellent profitability rating, but there are some minor concerns on its financial health. CVE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CVE was profitable.
In the past year CVE had a positive cash flow from operations.
CVE had positive earnings in 4 of the past 5 years.
In the past 5 years CVE always reported a positive cash flow from operatings.
CVE.CA Yearly Net Income VS EBIT VS OCF VS FCFCVE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

CVE has a better Return On Assets (5.83%) than 85.98% of its industry peers.
CVE has a better Return On Equity (11.00%) than 80.84% of its industry peers.
The Return On Invested Capital of CVE (7.09%) is better than 79.91% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CVE is significantly above the industry average of 6.73%.
The 3 year average ROIC (11.92%) for CVE is well above the current ROIC(7.09%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 5.83%
ROE 11%
ROIC 7.09%
ROA(3y)8.18%
ROA(5y)3.66%
ROE(3y)15.96%
ROE(5y)7.2%
ROIC(3y)11.92%
ROIC(5y)N/A
CVE.CA Yearly ROA, ROE, ROICCVE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

The Profit Margin of CVE (6.17%) is comparable to the rest of the industry.
CVE's Profit Margin has declined in the last couple of years.
CVE has a Operating Margin of 8.46%. This is comparable to the rest of the industry: CVE outperforms 51.40% of its industry peers.
CVE's Operating Margin has improved in the last couple of years.
CVE has a Gross Margin (33.16%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CVE has declined.
Industry RankSector Rank
OM 8.46%
PM (TTM) 6.17%
GM 33.16%
OM growth 3Y-3.42%
OM growth 5Y2.33%
PM growth 3Y68.65%
PM growth 5Y-12.05%
GM growth 3Y-13%
GM growth 5Y-11.02%
CVE.CA Yearly Profit, Operating, Gross MarginsCVE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CVE is creating some value.
The number of shares outstanding for CVE has been reduced compared to 1 year ago.
CVE has more shares outstanding than it did 5 years ago.
CVE has a worse debt/assets ratio than last year.
CVE.CA Yearly Shares OutstandingCVE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CVE.CA Yearly Total Debt VS Total AssetsCVE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

CVE has an Altman-Z score of 2.70. This is not the best score and indicates that CVE is in the grey zone with still only limited risk for bankruptcy at the moment.
CVE's Altman-Z score of 2.70 is fine compared to the rest of the industry. CVE outperforms 77.10% of its industry peers.
The Debt to FCF ratio of CVE is 3.55, which is a good value as it means it would take CVE, 3.55 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.55, CVE belongs to the top of the industry, outperforming 84.11% of the companies in the same industry.
A Debt/Equity ratio of 0.34 indicates that CVE is not too dependend on debt financing.
CVE has a Debt to Equity ratio (0.34) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 3.55
Altman-Z 2.7
ROIC/WACC0.98
WACC7.22%
CVE.CA Yearly LT Debt VS Equity VS FCFCVE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

CVE has a Current Ratio of 1.73. This is a normal value and indicates that CVE is financially healthy and should not expect problems in meeting its short term obligations.
CVE has a better Current ratio (1.73) than 75.70% of its industry peers.
A Quick Ratio of 1.18 indicates that CVE should not have too much problems paying its short term obligations.
CVE has a Quick ratio of 1.18. This is in the better half of the industry: CVE outperforms 68.69% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.18
CVE.CA Yearly Current Assets VS Current LiabilitesCVE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

5

3. Growth

3.1 Past

The earnings per share for CVE have decreased strongly by -12.76% in the last year.
Measured over the past years, CVE shows a very strong growth in Earnings Per Share. The EPS has been growing by 33.97% on average per year.
The Revenue has decreased by -9.17% in the past year.
CVE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.88% yearly.
EPS 1Y (TTM)-12.76%
EPS 3Y87.2%
EPS 5Y33.97%
EPS Q2Q%71.43%
Revenue 1Y (TTM)-9.17%
Revenue growth 3Y5.4%
Revenue growth 5Y21.88%
Sales Q2Q%-7.4%

3.2 Future

The Earnings Per Share is expected to grow by 23.27% on average over the next years. This is a very strong growth
CVE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.51% yearly.
EPS Next Y7.08%
EPS Next 2Y-1.25%
EPS Next 3Y14.64%
EPS Next 5Y23.27%
Revenue Next Year-8.83%
Revenue Next 2Y-5.31%
Revenue Next 3Y-3.51%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CVE.CA Yearly Revenue VS EstimatesCVE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B
CVE.CA Yearly EPS VS EstimatesCVE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 -2 4

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.85, CVE is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of CVE indicates a somewhat cheap valuation: CVE is cheaper than 65.89% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.89, CVE is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 15.88, the valuation of CVE can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CVE is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.59, CVE is valued rather cheaply.
Industry RankSector Rank
PE 14.85
Fwd PE 15.88
CVE.CA Price Earnings VS Forward Price EarningsCVE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CVE's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CVE is cheaper than 85.05% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CVE indicates a somewhat cheap valuation: CVE is cheaper than 66.36% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.08
EV/EBITDA 5.74
CVE.CA Per share dataCVE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CVE does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of CVE may justify a higher PE ratio.
CVE's earnings are expected to grow with 14.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.1
PEG (5Y)0.44
EPS Next 2Y-1.25%
EPS Next 3Y14.64%

5

5. Dividend

5.1 Amount

CVE has a Yearly Dividend Yield of 3.20%.
CVE's Dividend Yield is a higher than the industry average which is at 5.31.
CVE's Dividend Yield is a higher than the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 3.2%

5.2 History

The dividend of CVE is nicely growing with an annual growth rate of 31.72%!
CVE has been paying a dividend for at least 10 years, so it has a reliable track record.
CVE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)31.72%
Div Incr Years4
Div Non Decr Years4
CVE.CA Yearly Dividends per shareCVE.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

45.02% of the earnings are spent on dividend by CVE. This is a bit on the high side, but may be sustainable.
CVE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP45.02%
EPS Next 2Y-1.25%
EPS Next 3Y14.64%
CVE.CA Yearly Income VS Free CF VS DividendCVE.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B
CVE.CA Dividend Payout.CVE.CA Dividend Payout, showing the Payout Ratio.CVE.CA Dividend Payout.PayoutRetained Earnings

CENOVUS ENERGY INC

TSX:CVE (11/14/2025, 7:00:00 PM)

25.4

+0.37 (+1.48%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)10-31 2025-10-31/bmo
Earnings (Next)02-18 2026-02-18/amc
Inst Owners51.38%
Inst Owner ChangeN/A
Ins Owners0.67%
Ins Owner ChangeN/A
Market Cap45.40B
Revenue(TTM)50.56B
Net Income(TTM)3.12B
Analysts80.95
Price Target28.06 (10.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.2%
Yearly Dividend0.84
Dividend Growth(5Y)31.72%
DP45.02%
Div Incr Years4
Div Non Decr Years4
Ex-Date12-15 2025-12-15 (0.2)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)108.83%
Min EPS beat(2)40.05%
Max EPS beat(2)177.6%
EPS beat(4)3
Avg EPS beat(4)42.59%
Min EPS beat(4)-72.97%
Max EPS beat(4)177.6%
EPS beat(8)4
Avg EPS beat(8)19.19%
EPS beat(12)7
Avg EPS beat(12)10.58%
EPS beat(16)9
Avg EPS beat(16)-1.72%
Revenue beat(2)0
Avg Revenue beat(2)-4.56%
Min Revenue beat(2)-4.97%
Max Revenue beat(2)-4.15%
Revenue beat(4)0
Avg Revenue beat(4)-6.25%
Min Revenue beat(4)-10.43%
Max Revenue beat(4)-4.15%
Revenue beat(8)3
Avg Revenue beat(8)-1.58%
Revenue beat(12)5
Avg Revenue beat(12)-0.2%
Revenue beat(16)9
Avg Revenue beat(16)4.49%
PT rev (1m)2.61%
PT rev (3m)6.93%
EPS NQ rev (1m)-9.76%
EPS NQ rev (3m)-24.69%
EPS NY rev (1m)8.57%
EPS NY rev (3m)0.44%
Revenue NQ rev (1m)-3.58%
Revenue NQ rev (3m)8.13%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)3.23%
Valuation
Industry RankSector Rank
PE 14.85
Fwd PE 15.88
P/S 0.9
P/FCF 16.08
P/OCF 5.78
P/B 1.6
P/tB 1.78
EV/EBITDA 5.74
EPS(TTM)1.71
EY6.73%
EPS(NY)1.6
Fwd EY6.3%
FCF(TTM)1.58
FCFY6.22%
OCF(TTM)4.39
OCFY17.29%
SpS28.29
BVpS15.88
TBVpS14.24
PEG (NY)2.1
PEG (5Y)0.44
Graham Number24.71
Profitability
Industry RankSector Rank
ROA 5.83%
ROE 11%
ROCE 8.93%
ROIC 7.09%
ROICexc 7.38%
ROICexgc 7.88%
OM 8.46%
PM (TTM) 6.17%
GM 33.16%
FCFM 5.59%
ROA(3y)8.18%
ROA(5y)3.66%
ROE(3y)15.96%
ROE(5y)7.2%
ROIC(3y)11.92%
ROIC(5y)N/A
ROICexc(3y)12.89%
ROICexc(5y)N/A
ROICexgc(3y)13.8%
ROICexgc(5y)N/A
ROCE(3y)15.07%
ROCE(5y)N/A
ROICexgc growth 3Y-0.51%
ROICexgc growth 5Y16.37%
ROICexc growth 3Y0.11%
ROICexc growth 5Y16.58%
OM growth 3Y-3.42%
OM growth 5Y2.33%
PM growth 3Y68.65%
PM growth 5Y-12.05%
GM growth 3Y-13%
GM growth 5Y-11.02%
F-Score5
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 3.55
Debt/EBITDA 1.04
Cap/Depr 99.6%
Cap/Sales 9.94%
Interest Coverage 250
Cash Conversion 84.18%
Profit Quality 90.48%
Current Ratio 1.73
Quick Ratio 1.18
Altman-Z 2.7
F-Score5
WACC7.22%
ROIC/WACC0.98
Cap/Depr(3y)91.58%
Cap/Depr(5y)68.62%
Cap/Sales(3y)7.67%
Cap/Sales(5y)7.01%
Profit Quality(3y)110.56%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.76%
EPS 3Y87.2%
EPS 5Y33.97%
EPS Q2Q%71.43%
EPS Next Y7.08%
EPS Next 2Y-1.25%
EPS Next 3Y14.64%
EPS Next 5Y23.27%
Revenue 1Y (TTM)-9.17%
Revenue growth 3Y5.4%
Revenue growth 5Y21.88%
Sales Q2Q%-7.4%
Revenue Next Year-8.83%
Revenue Next 2Y-5.31%
Revenue Next 3Y-3.51%
Revenue Next 5YN/A
EBIT growth 1Y-20.33%
EBIT growth 3Y1.79%
EBIT growth 5Y24.73%
EBIT Next Year100.67%
EBIT Next 3Y28.05%
EBIT Next 5Y20.73%
FCF growth 1Y-6.18%
FCF growth 3Y7.94%
FCF growth 5Y14.96%
OCF growth 1Y5.9%
OCF growth 3Y15.98%
OCF growth 5Y22.96%

CENOVUS ENERGY INC / CVE.CA FAQ

What is the fundamental rating for CVE stock?

ChartMill assigns a fundamental rating of 6 / 10 to CVE.CA.


What is the valuation status for CVE stock?

ChartMill assigns a valuation rating of 5 / 10 to CENOVUS ENERGY INC (CVE.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for CENOVUS ENERGY INC?

CENOVUS ENERGY INC (CVE.CA) has a profitability rating of 7 / 10.


What is the valuation of CENOVUS ENERGY INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CENOVUS ENERGY INC (CVE.CA) is 14.85 and the Price/Book (PB) ratio is 1.6.


What is the financial health of CENOVUS ENERGY INC (CVE.CA) stock?

The financial health rating of CENOVUS ENERGY INC (CVE.CA) is 6 / 10.